Sector: MedicalACCP (OTCBB: ACCP)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 237 |
Technical : | 216 |
Performance : | 269 |
Overall: | 282 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 234 |
Technical : | 188 |
Performance : | 282 |
Overall: | 279 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 232 |
Technical : | 230 |
Performance : | 257 |
Overall: | 287 |
Number of Stocks: | 306 |
Headlines
- ChangeWave Issues Buy Recommendation on Access Pharmaceuticals
Nov 17, 2009 09:01 AM | ACCP
- Access Pharma (OTC: ACCP.OB): MuGard Launch Expected 1Q10
Nov 11, 2009 10:53 AM | ACCP
- Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America
Nov 11, 2009 09:02 AM | ACCP
- Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
Oct 15, 2009 08:01 AM | ACCP
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- Access Pharma, iMedicor Sign e-Marketing Deal for MuGard
Oct 06, 2009 10:18 AM | ACCP
- iMedicor Signs Agreement With Access Pharmaceuticals For the North American Commercial Launch of MUGARD(TM)
Oct 06, 2009 08:30 AM | ACCP
- Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)
Oct 06, 2009 08:03 AM | ACCP
- Access Pharma (OTC: ACCP.OB): MuGard, Pipeline Makes for Appealing Acquisition Possibilities
Sep 29, 2009 03:36 PM | ACCP, ALTH, BBI, BIIB, CTIC, MEDX
- Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States
Sep 11, 2009 09:00 AM | ACCP
- Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
Aug 03, 2009 06:02 AM | ACCP
- ProActiveNewsRoom Announces Interview With Jeffrey Davis, CEO of Access Pharmaceuticals
Jul 29, 2009 10:22 AM | ACCP
- Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Jul 29, 2009 09:03 AM | ACCP
- Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
Jul 27, 2009 09:07 AM | ACCP
- MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
Jul 23, 2009 09:03 AM | ACCP
- UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
Jul 22, 2009 11:11 AM | ACCP
- Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock Conference
Jul 22, 2009 09:04 AM | ACCP
- Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Jul 13, 2009 08:31 AM | ACCP, CYTX, ECTE, JLI, NABI
- Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
Jul 07, 2009 09:02 AM | ACCP
- Accor is Studying a Voluntary Separation Plan to Adjust its Headquarters Staff
Jun 30, 2009 01:40 PM | ACCP
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ACCP
|
Compare to S&P
|
| YTD |
217.17 %
|
161.99 %
|
| 4 Weeks |
-7.37 %
|
-7.87 %
|
| 12 Weeks |
-21.50 %
|
-26.33 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -16.33 %
|
|
EPS Growth in Last Year: -3.64 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -54.55 %
|
|
